Related Experiment Video
Updated: Dec 14, 2025

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
Published on: May 21, 2018
Lactoferrin-Derived Peptide Lactofungin Is Potently Synergistic with Amphotericin B
Kenya E Fernandes1, Richard J Payne2, Dee A Carter3
1School of Life and Environmental Sciences and the Marie Bashir Institute for Infectious Diseases and Biosecurity, University of Sydney, Sydney, NSW, Australia.
Abstract:
Lactoferrin (LF) is an iron-binding glycoprotein with broad-spectrum antimicrobial activity. Previously, we discovered that LF synergistically enhanced the antifungal efficacy of amphotericin B (AMB) across a variety of yeast species and subsequently hypothesized that this synergy was enhanced by the presence of small peptides derived from the whole LF molecule. In this study, LF was digested with pepsin under a range of conditions. The resulting hydrolysates exhibited enhanced synergy with AMB compared to its synergy with undigested LF. Samples were analyzed using matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometry, and 14 peptides were identified. The sequences of these peptides were predicted by matching their molecular weights to those of a virtual digest with pepsin. The relative intensities of predicted peptides in each hydrolysate were compared with the activity of the hydrolysate, and the structural and physicochemical properties of the peptides were assessed. From this, a 30-residue peptide was selected for synthesis and dubbed lactofungin (LFG). Pure LFG was highly synergistic with AMB, outperforming native LF in all fungal species tested. With potential for further structural and chemical improvements, LFG is an excellent lead for development as an antifungal adjuvant.
Insights
Lactoferrin peptides significantly boost the antifungal power of amphotericin B. A synthesized peptide, lactofungin, shows superior synergy, offering a promising new antifungal adjuvant.
Area of Science:
- Biochemistry
- Mycology
- Pharmacology
Background:
- Lactoferrin (LF) possesses broad-spectrum antimicrobial properties.
- LF synergistically enhances antifungal drug efficacy, particularly with amphotericin B (AMB).
- Hypothesis: Peptides derived from LF may further augment this synergy.
Purpose of the Study:
- To investigate if pepsin-derived peptides from LF enhance AMB's antifungal activity.
- To identify specific peptides responsible for enhanced synergy.
- To develop a novel peptide-based antifungal adjuvant.
Main Methods:
- Pepsin digestion of LF under various conditions.
- Antifungal synergy assays with AMB and LF hydrolysates.
- Peptide identification using MALDI-TOF mass spectrometry.
- Virtual peptide digest analysis and sequence prediction.
- Synthesis and testing of a lead peptide, lactofungin (LFG).
Main Results:
- LF hydrolysates showed enhanced synergy with AMB compared to intact LF.
- Fourteen peptides were identified, with sequences predicted.
- A 30-residue peptide, lactofungin (LFG), was synthesized.
- Pure LFG demonstrated potent synergy with AMB, surpassing native LF's efficacy across tested fungal species.
Conclusions:
- Pepsin-derived peptides from LF significantly enhance AMB antifungal activity.
- LFG is a highly effective antifungal adjuvant with potential for further optimization.
- LFG represents a promising lead compound for developing novel antifungal therapies.
Related Concept Videos
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Overview of Fungi
Fungal Group Zygomycota

